Multiple Sclerosis and Demyelinating Diseases: Diagnosis, Treatment and Prognosis
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Neurology".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 1091
Special Issue Editor
Interests: neurological disorders; neurological diseases; multiple sclerosis; demyelinating diseases; immunomodulators
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Special Issue of the Journal of Clinical Medicine titled "Multiple Sclerosis and Demyelinating Diseases: Diagnosis, Treatment and Prognosis" delves into the latest advancements in understanding and managing demyelinating diseases, with a particular focus on Multiple Sclerosis (MS). This collection features original research, clinical studies, and reviews that address diagnostic challenges, therapeutic innovations, and prognostic factors impacting patient outcomes. By integrating insights from neurology, immunology, and clinical practice, the issue aims to enhance the accuracy of MS diagnosis, evaluate emerging treatment options, and offer a comprehensive outlook on improving patient care and quality of life for those affected by these complex conditions.
Dr. Alberto Gajofatto
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multiple sclerosis
- neuromyelitis optica
- MOG-antibody disease
- diagnosis
- prognosis
- treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
